Propiedad y actividad de insiders de RxSight, Inc. (RXST): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $5.40 |
| Capitalización | $224M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-15 | Weinberg Eric | M-Exempt | 35,168 | $153K |
| 2026-09-15 | Weinberg Eric | M-Exempt | 35,168 | $153K |
| 2026-09-05 | Wilterding Mark | A-Award | 258,770 | $1.6M |
| 2026-09-05 | Wilterding Mark | D-Return | 258,770 | $2.6M |
| 2026-09-05 | Weinberg Eric | A-Award | 93,984 | $599K |
| 2026-09-05 | Weinberg Eric | A-Award | 82,608 | $527K |
| 2026-09-05 | Weinberg Eric | A-Award | 65,742 | $419K |
| 2026-09-05 | Weinberg Eric | A-Award | 59,483 | $379K |
| 2026-09-05 | Weinberg Eric | A-Award | 32,258 | $206K |
| 2026-09-05 | Weinberg Eric | D-Return | 95,000 | $1.4M |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8.0M | $14.0M | $24.4M | $11.8M | $9.7M | $16.7M | $19.9M |
| Inversiones a Corto | $72.7M | $55.0M | $135.0M | $94.0M | $117.5M | $220.5M | $208.2M |
| Cuentas por Cobrar | $789000 | $2.9M | $4.9M | $11.0M | $20.3M | $30.1M | $23.4M |
| Inventario | $7.2M | $8.3M | $8.0M | $14.8M | $17.4M | $22.0M | $31.6M |
| Activos Corrientes | $90.2M | $81.5M | $176.3M | $134.6M | $168.4M | $293.8M | $287.5M |
| Inmovilizado Material | $19.2M | $18.6M | $15.5M | $14.1M | $13.3M | $23.6M | $23.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $110.4M | $100.7M | $192.7M | $150.2M | $182.6M | $318.6M | $311.8M |
| Cuentas por Pagar | $2.2M | $1.1M | $1.7M | $2.6M | $3.9M | $4.5M | $5.3M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $974000 | 0 |
| Pasivos Corrientes | $8.5M | $11.6M | $11.1M | $17.2M | $20.9M | $25.9M | $26.3M |
| Deuda a Largo | 0 | $24.4M | $39.8M | $40.2M | 0 | 0 | $9.9M |
| Pasivos Totales | $415.0M | $398.2M | $54.5M | $60.3M | $22.2M | $37.3M | $36.1M |
| Reservas | -$419.9M | -$430.6M | -$479.3M | -$546.0M | -$594.6M | -$622.1M | -$661.0M |
| Patrimonio Neto | -$304.6M | -$297.5M | $138.2M | $89.9M | $160.4M | $281.2M | $275.7M |
| Deuda Total | $5.5M | $30.8M | $44.9M | $45.0M | $3.0M | $12.3M | $11.0M |
| Deuda Neta | -$75.2M | -$38.2M | -$114.4M | -$60.8M | -$124.2M | -$224.9M | -$217.1M |
| Capital Circulante | $81.7M | $69.9M | $165.2M | $117.3M | $147.5M | $267.9M | $261.2M |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 4.07 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 5.08 |
Rentabilidad
| Rentabilidad sobre capital | -17.35% |
| Rentabilidad sobre capital invertido | -20.12% |
| Rentabilidad sobre activos | -13.31% |
| Margen bruto | 77.50% |
| Margen operativo | -43.20% |
| Margen neto | -36.80% |
Empresas relacionadas: BFLY · CERS · DCTH · DMAC · KIDS · NPCE · SMLR
Explorar sector: Healthcare · Medical - Devices
Más secciones de RXST: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones